Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endocrine disorders and osteoporosis

C J Rosen1

  • 1St. Joseph Hospital, Bangor, ME 04401, USA.

Current Opinion in Rheumatology
|July 1, 1997
PubMed
Summary

Endocrine disorders are common causes of secondary osteoporosis. Addressing hormonal imbalances can improve bone mineral density and reduce fracture risk, highlighting their importance in bone health management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IGF-1 is associated with estimated bone strength in anorexia nervosa.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019
Same author

Clinical implications of bone marrow adiposity.

Journal of internal medicine·2017
Same author

Type 2 Diabetes and Aging: A Not so Sweet Scenario for Bone.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2016
Same author

HP1BP3 expression determines maternal behavior and offspring survival.

Genes, brain, and behavior·2016
Same author

PPARG Post-translational Modifications Regulate Bone Formation and Bone Resorption.

EBioMedicine·2016
Same author

Daily leptin blunts marrow fat but does not impact bone mass in calorie-restricted mice.

The Journal of endocrinology·2016

Area of Science:

  • Endocrinology
  • Bone Biology
  • Metabolic Diseases

Background:

  • Endocrine disorders are a leading cause of secondary osteoporosis in both men and women.
  • Common endocrine conditions like diabetes mellitus, hyperparathyroidism, and hyperthyroidism significantly impact bone health.
  • The complex pathogenesis of hormone-induced bone loss involves the bone remodeling cycle and requires further elucidation.

Purpose of the Study:

  • To review recent research on hormonal disorders affecting the skeleton.
  • To examine the impact of diabetes mellitus, hyperparathyroidism, and hyperthyroidism on bone loss and fracture risk.
  • To emphasize the role of endocrine diseases in the differential diagnosis and management of osteopenia.

Main Methods:

  • Literature review of recent studies on hormonal disorders and skeletal health.
  • Analysis of the mechanisms of hormone-induced bone loss.
  • Focus on specific endocrine conditions: diabetes mellitus, hyperparathyroidism, and hyperthyroidism.

Main Results:

  • Endocrine disorders are frequently implicated in secondary osteoporosis.
  • Correction of endocrine gland hypo- or hyperfunction can lead to improved bone mineral density.
  • These hormonal conditions contribute to accelerated bone loss and increased fracture risk.

Conclusions:

  • Endocrine disorders are critical considerations in the diagnosis and treatment of osteoporosis and osteopenia.
  • Understanding and managing hormonal imbalances are key to improving skeletal health.
  • Further research is needed to fully elucidate the pathogenesis of hormone-induced bone loss.

Related Experiment Videos